InstantWhyThe decision
MarketWatch reports that the personal consumption expenditures price index, the inflation measure the Federal Reserve relies on most heavily, fell in June for the first time since the pandemic began. The report is not yet independently confirmed. The decline came in the same week the Fed decided to hold interest rates unchanged, a move that sent the Dow down sharply as investors had hoped for signals that cuts were coming.
Why it matters
Chair Kevin Warsh and his colleagues are treating a single month's decline as progress, not proof that inflation is beaten, which is why markets sold off after the hold decision. The Fed is waiting for a sustained trend before easing policy, and one data point does not make that case.
How we got here
The Fed held rates steady on July 29, disappointing investors who had hoped for dovish signals, and the Dow fell 1,100 points in its worst session since April 2025. Warsh's remarks that day failed to calm markets, as he emphasized the central bank's focus on bringing inflation down durably rather than reacting to any single report. Investors had braced for a pivotal week of Fed decisions, Big Tech earnings and fresh inflation data, and the combination delivered volatility.
What happens next
The Fed will be watching whether the June decline in the PCE index continues in coming months or proves to be a one-time event. Further drops would build the case for rate cuts later this year, while a rebound would validate the central bank's caution. The next PCE report and the Fed's September meeting will clarify whether this marks a turning point or a temporary dip.
- ✓Detected and written at 2026-07-30 14:08
- ✓First reported by MarketWatch
- ✓Written from public facts in our own words — never a copy
- ✓Published as fast as possible; our team holds editorial responsibility
Sources
- MarketWatch — Top Stories: https://www.marketwatch.com/story/fed-favored-pce-inflation-gauge-falls-for-first-time-since-pandemic-but-danger-far-from-over-57e382bf?mod=mw_rss_topstories
More stories
InstantWhyProcter & Gamble to acquire supplements brand Thorne in health business expansion
InstantWhyTwo charged in federal drug trafficking probe in southern Maryland
InstantWhy